Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(Acute myelocytic myelogenous leukemia AML )
423 results
  • VEGFC antibody therapy drives differentiation of AML. [Journal Article]
  • CRCancer Res 2018 Sep 05
  • Kampen KR, Scherpen FJG, … De Bont ES
  • High expression of vascular endothelial growth factor C (VEGFC) predicts adverse prognosis in acute myeloid leukemia (AML). We therefore explored VEGFC targeting efficacy as an AML therapy using a VE...
New Search Next